{"transactions":[{"id":11987,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11009,"kind":"person","name":"Crum Demetris D","position":1,"cik":"0002078592","reported_name":"Crum Demetris D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-06T22:02:27.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1594,"price":232.08,"value":369935.52,"ownership":{"direct":true},"balance_after":7914,"source":{"system":"sec-edgar","filing":"0002078592-26-000004","document":"form4-03062026_100324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000207859226000004/form4-03062026_100324.xml","form_type":"4"}},{"id":13199,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11009,"kind":"person","name":"Crum Demetris D","position":1,"cik":"0002078592","reported_name":"Crum Demetris D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Option (Right to buy)","published_at":"2026-02-20T23:35:14.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":13406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,469 on February 18, 2027, 4,469 on February 18, 2028, and 4,468 on February 18, 2029."}],"balance_after":13406,"derivative":{"exercise_price":230.04,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":13406},"source":{"system":"sec-edgar","filing":"0002078592-26-000002","document":"form4-02202026_060208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000207859226000002/form4-02202026_060208.xml","form_type":"4"}},{"id":13198,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11009,"kind":"person","name":"Crum Demetris D","position":1,"cik":"0002078592","reported_name":"Crum Demetris D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:14.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":1244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 13, 2025. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":9508,"source":{"system":"sec-edgar","filing":"0002078592-26-000002","document":"form4-02202026_060208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000207859226000002/form4-02202026_060208.xml","form_type":"4"}},{"id":13197,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11009,"kind":"person","name":"Crum Demetris D","position":1,"cik":"0002078592","reported_name":"Crum Demetris D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF HR OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:14.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":1216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":8264,"source":{"system":"sec-edgar","filing":"0002078592-26-000002","document":"form4-02202026_060208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000207859226000002/form4-02202026_060208.xml","form_type":"4"}}]}